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SUMMARY – The aim is to present a patient with severe bilateral corneal complications after 
long-term antiglaucoma treatment with 1% pilocarpine hydrochloride (Pilokarpin, Pliva, Zagreb, 
Croatia) and its management. A patient with narrow-angle glaucoma treated with 1% topical pilo-
carpine hydrochloride eye drops for the last twenty years complained of impaired vision, intermi-
ttent visual haloes and eye redness. Ophthalmologic examination showed bilateral band keratopathy, 
peripheral laser iridotomy, medicamentous myosis, brown nuclear cataract, and synchysis scintillans 
of his right eye. Band keratopathy was thought to have resulted from the presence of the preserva-
tive phenylmercuric nitrate in the pilocarpine hydrochloride eye drops. Treatment of the patient 
consisted of two separate procedures for both eyes, i.e. phaco trabeculectomy and six months later 
corneal procedure including abrasion of corneal epithelium followed by removal of the superficial 
stromal calcium deposits by means of a 3.75% ethylenediaminetetraacetic (EDTA) solution. After 
phaco trabeculectomy, visual acuity was 0.8 on both eyes. Bilateral visual improvement with visual 
acuity 1.0 was recorded after corneal treatment with EDTA. In conclusion, one must be aware of 
preservative complications in long-term topical use, such as band keratopathy that can be visually in-
capacitating. Surgical treatment using EDTA is safe and effective treatment for band keratopathy.
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Introduction 
Band keratopathy is a corneal degenerative disease 
associated with a variety of different ocular and sys-
temic pathologic conditions. Its name derives from 
the distinctive appearance of calcium deposits in a 
band across the central interpalpebral corneal area. It 
is thought to result from precipitation of calcium salts 
on the corneal surface under the epithelium. Calcium 
salts can normally be found in serum or normal body 
fluids such as tears and humor aqueous. Central in-
trapalpebral corneal area shows greatest evaporations 
of tears tending to concentrate solutes. Systemic con-
ditions with elevated serum calcium or serum phos-
phate can favor precipitation. Local conditions such 
as chronically inflamed eyes cause elevation of the eye 
surface pH that also favors precipitation. 
Eye preservative complications have been de-
scribed and reported1-3 many times since their first 
use, while playing no significant role in short-term 
treatment. Glaucoma patients present a specific long-
term treatment group with topical treatment that lasts 
for decades. Such length of treatment is the reason for 
the high incidence of preservative complications4-6.
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Pilocarpine as an antiglaucoma medication is not 
frequently used today, although it is necessary in some 
specific cases. The exact incidence of calcium band 
keratopathy is unknown. 
Surgical treatment of band keratopathy usually 
consists of removal of the corneal epithelium followed 
by removal of the subepithelial calcium deposits by 
means of ethylenediaminetetraacetic acid (EDTA) 
solution. EDTA has been used in such conditions for 
chelation of calcium ions. Chelator is not a solvent 
and does not dissolve anything. It is safe and effective 
treatment for calcium corneal deposits, although it is 
used ‘off label’.
In order to reduce discomfort and postoperative 
pain that occurs after corneal abrasion, several modi-
fied methods have been developed using amniotic 
membrane7, laser epithelial keratomileusis (LASEK)8, 
bandage soft contact lens and phototherapeutic kera-
tectomy9, or their combination. 
Case Report
A 65-year-old male patient was referred to the 
hospital for antiglaucoma surgery. He had a history 
of narrow angle glaucoma for the last twenty years. 
Nd:Yag laser iridotomy was done years before on both 
eyes, followed by treatment with topical 1% pilo-
carpine hydrochloride (Pilokarpin, Pliva, Zagreb, 
Croatia) eye drops three times daily ever since. In the 
last 12 months, he was complaining of impaired vi-
sion and intermittent visual haloes and occasional eye 
redness. 
Ophthalmologic examination showed his best-
corrected visual acuity (BCVA) of 0.075 on both eyes. 
Slit lamp examination revealed bilateral corneal band 
calcium deposits located in the subepithelial layer, la-
ser peripheral iridotomies at 12 hours, medicamentous 
miosis, corticonuclear bilateral dark-brown cataract, 
and synchysis scintillans on his right eye. 
The patient had no history of any systemic disease 
and was not taking any medications except for anti-
glaucoma eye drops. He had no family history of cor-
neal disease and no history of trauma, arthropathy or 
inflammatory eye disease.
Thorough systemic evaluation did not reveal any 
abnormality. Routine hemogram was unremarkable. 
Serum levels of calcium and phosphorus, alkaline 
phosphatase, glucose, urea nitrogen and uric acid were 
normal. Since we did not find any local or systemic 
disease as the cause of the patient’s band keratopathy, 
we considered it to have resulted from the presence 
of the preservative phenylmercuric nitrate in the pilo-
carpine hydrochloride eye drops.
Methods
Since our patient had multiple ocular pathologies, 
we decided to divide his treatment into two separate 
procedures for both eyes, as we could not establish 
how much the corneal deposits influenced his loss of 
vision. In the first procedure, mitomycin C enhanced 
fornix based trabeculectomy combined with pha-
coemulsification and intraocular acrylic lens implan-
tation through a single incision was performed on the 
right eye and then on the left eye. Antiglaucoma eye 
drops were excluded after the first procedure.
Since visual axis was not clear six months after the 
first procedure, surgical corneal procedure in topical 
anesthesia including abrasion of corneal epithelium 
followed by removal of the superficial stromal calcium 
deposits by means of a 3.75% EDTA solution was per-
formed. Cellular sponge soaked in the 3.75% EDTA 
solution was applied onto corneal deposits and kept 
for about 10 minutes, scraping several times avoid-
ing central corneal zone. After white calcific deposits 
were dissolved, corneal surface was well irrigated with 
saline, bandage soft contact lens was placed and anti-
biotic eye drops were prescribed for seven days. 
Results
After mitomycin C enhanced trabeculectomy 
combined with phacoemulsification and intraocular 
acrylic lens implantation, antiglaucoma topical thera-
py was excluded. At one month of the first procedure, 
BCVA was 0.8 on both eyes. Slit lamp examination 
showed conjunctival diffuse filtration bleb, band of 
calcific deposits and pseudophakia. Fundus examina-
tion showed no pathology. Intraocular pressure was 
8-12 mm Hg.
Second procedure consisted of surgical corneal 
procedure including abrasion of corneal epithelium 
followed by removal of the superficial stromal calcium 
deposits with 3.75% EDTA solution. Follow up af-
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ter second procedure was done at days 7, 14, 30 and 
90, then at 12 and 24 months. Fourteen days after 
the second procedure, BCVA was 1.0 on both eyes. 
Removing corneal calcific deposits improved BCVA 
by two lines on Snellen charts. Intraocular pressure 
was 8-12 mm Hg. At 24-month follow up, BCVA 
and intraocular pressure were not changed. Slit lamp 
examination showed no recurrence or any other com-
plication. Corneal surface stayed clear and smooth. 
The patient experienced no haloes or any other visual 
disturbances.
Discussion
Band keratopathy is a chronic degenerative condi-
tion commonly seen in association with a variety of 
other ocular and systemic conditions such as uveitis, 
absolute glaucoma, phthisis, chronic corneal edema, 
silicon oil and viscoelastic agents, steroid phosphate 
preparations, hypercalcemia and chemical burns. The 
condition can also be familial and idiopathic.
We found none of these causes to be responsible 
for corneal deposits in our patient.
In 1966, Charney reported a case described as 
idiopathic band keratopathy with no other ocular or 
systemic findings, and treated for eight years with 
miotics for glaucoma10. Five years later, Kennedy et 
al. reported atypical band keratopathy in 18 glaucoma 
patients on long-term miotic therapy11. It was then 
concluded for the first time that all affected individu-
als used pilocarpine made by one manufacturer, which 
differed from other brands available by containing 
phenylmercuric nitrate as a preservative agent. Since 
then, phenylmercuric nitrate has no longer been used 
in pilocarpine drops in western countries, but has still 
been present in some drops prescribed for glaucoma 
and antibiotic preparations. 
In 1986, Douglas et al. reported similar corneal 
changes during pilocarpine gel therapy12. The exact 
mechanism of such corneal calcific deposits has not 
yet been precisely explained nor is the exact incidence 
of calcium band keratopathy known. 
By pathological findings, band keratopathy is di-
vided into two different subtypes according to the 
impacted layer, i.e. superficial type and deep type. It 
is also divided into three stages according to symp-
toms and disruption of the ocular surface. Our patient 
had superficial type medium stage band keratopathy, 
which can be considered as the reason for good re-
sult and fast recovery leaving no postoperative corneal 
haze. EDTA applied for about 10 minutes dissolved 
calcific deposits in the central corneal area because 
they were superficial and not too thick. We did few 
gentle peripheral corneal zone scrapings near limbus 
using blunt spatula outside the visual axis to remove 
thicker deposits. If deposits were much thicker, then 
EDTA can be instilled for much longer until calcium 
plague is dissolved completely. Deep corneal stromal 
deposits leaving defect could potentially delay healing 
and would ask for another approach like superficial 
lamellar keratectomy, phototherapeutic keratectomy, 
LASEK, amniotic membrane transplantation, and 
their combination. 
It is also known that exposure to mercury vapor 
causes brown discoloration of the anterior lens cap-
sule13, so called mercurialentis. The same effect is 
exerted with phenylmercuric nitrate as preservative. 
Such dark-brown colored cataract was the cataract 
that our patient had on his both eyes. 
At 24-month follow up, our patient had no recur-
rence, although Najjar et al. report a high incidence 
of late recurrence, with a case of recurrence even after 
17 years14. However, early and high recurrence rate is 
expected in rare familial calcific band keratopathy15. 
Since our patient has no family history, no systemic 
related diseases, and has been left without any topical 
medications, we presume he has a very little chance 
of recurrence. However, treatment with EDTA is re-
peatable. 
Commercial ophthalmic preparation for chelation 
such as EDTA is not available yet. EDTA is available 
as 100% solution that can easily be diluted with saline. 
Treatment with EDTA chelation proved to be surgi-
cally easy and safe procedure. 
Conclusion
Phenylmercuric nitrate is still used as a preser-
vative in some topical medications. In glaucoma pa-
tients, their long-term use can cause side effects that 
can lead to visual impairment. Treatment of band ker-
atopathy depends on its stage and subtype. EDTA as 
a chelation agent for corneal calcific plaque is a safe 
and effective method for its complete removal. The 
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procedure is simple and the results are excellent, with 
good recovery of vision. 
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Sažetak
KONZERVANS U OČNIM KAPIMA KAO UZROK POJASASTE KERATOPAIJE ROŽNICE KOD 
DUGOTRAJNE TERAPIJE PILOKARPIN HIDROKLORIDOM
 
J. Pavičić-Astaloš, V. Lacmanović-Lončar, I. Petric-Vicković, D. Šarić, Z. Mandić, T. Csik i N. Sušić
Cilj je prikazati slučaj nastanka rožničnih komplikacija uzrokovanih konzervansima pri dugotrajnoj upotrebi kapi 1%-
tnog pilokarpin hidroklorida (Pilokarpin, Pliva, Zagreb, Hrvatska) i njihovo liječenje. Bolesnik s glaukomom zatvorenog 
kuta koji se unazad dvadeset godina liječio antiglaukomskim kapima 1%-tnog pilokarpin hidroklorida tri puta na dan žalio 
se na slabiji vid, haloe i povremeno crvenilo očiju. Oftalmološkim pregledom nađene su obostrane pojasaste degeneracije 
rožnice, periferne laserske iriditomije, zjenice u medikamentnoj miozi, tamna nuklearna bilateralna katarakta i scintilira-
juća sinhiza desnog oka. Konzervans živin nitrat smatra se uzrokom pojasaste degeneracije rožnice kod ovoga bolesnika. 
Liječenje bolesnika sastojalo se od dva postupka za oba oka: prvi je bio kombinirani zahvat fakoemulzifikacije katarakte 
s trabekulektomijom, a nakon šest mjeseci liječenje koje je uključivalo abraziju kornealnog epitela i uklanjanje stromalnih 
kalcijskih depozita pomoću 3,75%-tne otopine etilendiamintetraoctene kiseline (EDTA). Vidna oštrina nakon fakotrabe-
kulektomije bila je 0,8 na oba oka. Obostrano poboljšanje vida do vidne oštrine 1,0 postiglo se nakon uklanjanja rožničnih 
depozita pomoću EDTA. Zaključuje se kako se prilikom dugotrajne upotrebe lijekova s konzervansima mogu očekivati 
nuspojave kao što je pojasasta degeneracija rožnice koja može doprinijeti znatnom smanjenju vidne oštrine. Kirurško lije-
čenje pomoću EDTA je sigurna i učinkovita metoda liječenja pojasaste degeneracije rožnice.
Ključne riječi: Pilokarpin hidroklorid; Pojasasta degeneracija; EDTA; Konzervansi u topikalnoj terapiji

